13F-HR filed by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 44 holding rows worth $5,806,523,000.
- Accession
- 0001104659-21-023460
- Filer
- CIK 1633313
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 44 entries on the cover page, a total value of $5,806,523,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,806,523,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 4,535,000 | $996,067,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 9,000,000 | $658,350,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 2,850,000 | $432,602,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 7,500,000 | $348,000,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 4,190,000 | $321,918,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,800,000 | $300,204,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,750,000 | $298,358,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 902,500 | $265,416,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 9,000,000 | $207,810,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,550,000 | $198,307,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 6,800,000 | $180,948,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,650,000 | $144,689,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,225,000 | $136,183,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 4,000,000 | $130,640,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,350,267 | $130,536,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,950,000 | $104,247,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 8,000,000 | $86,720,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 5,800,000 | $85,318,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 2,950,000 | $84,960,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,300,000 | $74,191,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 1,545,495 | $68,709,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 10,300,000 | $59,122,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 7,250,000 | $50,098,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,800,500 | $49,073,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,525,000 | $48,907,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,800,000 | $43,064,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 3,232,142 | $39,432,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 876,986 | $35,646,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 6,000,000 | $29,340,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 4,365,000 | $29,158,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 500,000 | $20,780,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 640,000 | $20,512,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 3,550,000 | $19,135,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 460,000 | $15,557,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 1,000,000 | $13,950,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 545,000 | $13,908,000 | thousands by filing date | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 1,670,000 | $12,442,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427401 | COMMON STOCK | 5,084,184 | $12,304,000 | thousands by filing date | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 3,500,000 | $10,955,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 450,000 | $10,008,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 800,000 | $9,152,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 452,500 | $5,661,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 372,500 | $4,120,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 100,000 | $26,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-023460 | this filing | 2021-02-16 | acceptance time not in the bulk data set |